Imperial College London
11 stories
-
healthAnti-Obesity Drug Set for Drastic Price Drop Post-Patent
New study reveals blockbuster anti-obesity and diabetes drug, semaglutide, could cost as little as $3 per month to manufacture, offering hope for wider access.
-
healthPsychedelic Compound Shows Promise in Cutting Depression Symptoms
A clinical study reveals that a single dose of DMT, a naturally occurring psychedelic, significantly reduced depression symptoms in participants.
-
healthAyahuasca Compound Shows Promise in Easing Depression
New research suggests a single dose of DMT, the active compound in ayahuasca, could significantly reduce depressive symptoms, offering a potential new avenue for treatment.